Koers Canopy Rivers Inc Toronto S.E.
Aandelen
CA1380411084
Farmaceutische producten
Omzet 2022 | 1,9 mln. 1,39 mln. 1,3 mln. | Omzet 2023 | 6,81 mln. 4,98 mln. 4,66 mln. | Marktkapitalisatie | 12,02 mln. 8,78 mln. 8,22 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -52 mln. -38,01 mln. -35,58 mln. | Nettowinst (verlies) 2023 | -179 mln. -131 mln. -122 mln. | EV/omzet 2022 | -69,8 x |
Nettoliquiditeiten 2022 | 298 mln. 218 mln. 204 mln. | Nettoschuld 2023 | 12,46 mln. 9,11 mln. 8,52 mln. | EV/omzet 2023 | 3,6 x |
K/w-verhouding 2022 |
-3,13
x | K/w-verhouding 2023 |
-0,08
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 84,84% |
Recentste transcriptie over Canopy Rivers Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mike Totzke
CEO | Chief Executive Officer | - | 20-06-22 |
Eddie Lucarelli
DFI | Director of Finance/CFO | - | 01-03-18 |
Amanda Rico
HRO | Human Resources Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 39 | 30-09-21 | |
Richard Mavrinac
BRD | Director/Board Member | 71 | 17-09-18 |
Chairman | - | 17-09-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+35,04% | 5,92 mld. | |
-15,13% | 4,51 mld. | |
-9,75% | 3,15 mld. | |
+2,14% | 3,1 mld. | |
-6,82% | 2,42 mld. | |
+47,87% | 1,97 mld. | |
-7,89% | 1,68 mld. | |
+0,09% | 1,65 mld. | |
-12,97% | 1,53 mld. |